Table 2.

Phenotypic outcome for carbapenem antibiotics from carbapenemase-producing strains.

Bacterial strains	Inhibition diameter (mm)			Patient's age (years)/sex
	Imipenem (10 μg)	Meropenem (10 μg)	Ertapenem (10 μg)
E. coli 471	24	24	23	70/M
E. coli 919	15	00	00	62/M
E. coli 1318	10	00	00	11/F
E. coli 1473	28	30	30	79/M
E. coli 1476	27	30	29	29/F
E. coli 403	25	28	25	79/M
E. coli 405	26	27	26	85/M
E. coli 513	27	28	26	Not specified
E. coli 514	29	24	15	42/M
E. coli 583	29	29	27	77/M
E. coli 596	24	29	27	25/F
E. coli 1321	28	28	30	72/F
E. coli 1831	25	26	21	60/M
E. coli 469	26	26	24	69/F
E. coli 543	26	26	25	83/M
CA-SFM acceptable limit for E. coli ATCC 25922	26–32	28–35	29–36
Target for E. coli ATCC 25922	29	31-32	32-33